...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: zenith deal?

I think it will be in the new taxation year before there will be an announcement.

Share
New Message
Please login to post a reply